- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00121940
Guided Care: Integrating High Tech and High Touch
The purpose of the study is to evaluate the effect of a Guided Care nurse on the quality of the health and well-being of the frail elderly. A specially trained registered nurse will work closely with 1-3 primary care physicians to provide the most complex older patients (and their unpaid caregivers) with health care that is comprehensive, coordinated, patient-centered, and proactive. The study will evaluate the effects of Guided Care on:
- older persons' physical and mental health, health services utilization, quality of care, self-efficacy, and satisfaction with care;
- older persons' unpaid caregivers' burden; and
- primary care physicians' satisfaction with their care of chronically ill patients.
Study Overview
Detailed Description
Health care for older Americans with chronic conditions is often fragmented and provider-centric. In response, a team of investigators at Johns Hopkins University has translated the scientific principles of seven successful innovations into one patient-centered system of care. Supported by evidence-based guidelines and state-of-the-art information technology, "Guided Care" is undergoing a 12-month pilot test in older primary care patients with complex needs. A specially trained Guided Care nurse (GCN), based in a primary care practice, collaborates with two primary care physicians to provide seven services for 40-60 high-risk patients: comprehensive assessment and care planning; "best practices" for chronic conditions; self-management; healthy lifestyles; coordinating care; educating and supporting unpaid caregivers; and accessing community resources.
The proposed multi-site study will measure the effects of Guided Care on the quality and outcomes of care for high-risk older persons, their unpaid caregivers, and their primary care physicians. The panels of 53 physicians in 7 practices will be screened to identify 1350 high-risk older patients. After about 850 have given informed consent and baseline interviews, clusters of 2-5 physicians at each practice site will be randomized to provide either Guided Care or usual care to their consenting patients. Each physician cluster in the Guided Care group will incorporate a GCN into its practice; the physician clusters in the control group will not.
Interviews and queries of administrative databases will provide evaluative data at baseline and at 12-, 24-, and 32-month follow-up intervals. The primary outcome variables are the participants' physical health and mental health (SF-36 Summary Scales) and health services utilization. Secondary outcome variables include: the quality of care; unpaid caregivers' burden; self-rated health; patient satisfaction; and primary care physicians' satisfaction. Intention-to-treat analyses will have 85% power (range of 70-97%) to detect clinically meaningful differences between the two groups.
The study is designed to facilitate the prompt dissemination of Guided Care, if the results of the trial are favorable. A stakeholders' advisory board, representing consumers, providers, delivery systems, insurers, regulators and policy-makers, will inform the operation and evaluation of the study - and it will facilitate the subsequent dissemination of its tools and technology throughout American health care.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21205
- Johns Hopkins University Bloomberg School of Public Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Over 65
- Insured by KPMAG, USFHP/TRICARE, or Medicare FFS
- High likelihood of use of services in the coming year based on predictive modeling using current year's health care expenses
Exclusion Criteria:
- Moving out of area
- Currently assigned to case manager/in case management program
- Cognitive impairment and no legal representative
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Usual Care
|
|
Experimental: Guided Care
|
Specially trained registered nurse (Guided Care Nurse) based in a primary care practice collaborates with two primary care physicians to provide seven services for 40-60 high-risk patients: comprehensive assessment and care planning; "best practices" for chronic conditions; self-management; healthy lifestyles; coordinating care; educating and supporting unpaid caregivers; and accessing community resources.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
SF-36 Physical Health Summary Scale
Time Frame: Baseline, 6, 18, and 32 months
|
Baseline, 6, 18, and 32 months
|
|
SF-36 Mental Health Summary Scale
Time Frame: Baseline, 6, 18, and 32 months
|
Baseline, 6, 18, and 32 months
|
|
Health Services Utilization
Time Frame: Baseline, 8, 20, and 32 months
|
Multiple utilization measures (e.g.
hospital admissions, SNF admissions, primary care visits, specialist visits) based on claims data
|
Baseline, 8, 20, and 32 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Perceived Quality of Care
Time Frame: Baseline, 6, 18, and 32 months
|
Using Patient Assessment of Chronic Illness Care (PACIC) and Primary Care Assessment Survey (PCAS)
|
Baseline, 6, 18, and 32 months
|
Patient Satisfaction with Care
Time Frame: Baseline, 6, 18, and 32 months
|
Baseline, 6, 18, and 32 months
|
|
Physician Satisfaction with Care
Time Frame: Baseline, 12, 24, and 36 months
|
Baseline, 12, 24, and 36 months
|
|
Caregiver Burden
Time Frame: Baseline, 6, and 18 months
|
Using Modified Caregiver Strain Index
|
Baseline, 6, and 18 months
|
Self-rated Health
Time Frame: Baseline, 6, 18, and 32 months
|
Baseline, 6, 18, and 32 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Charles Boult, MD, MPH, MBA, Johns Hopkins Bloomberg School of Public Health
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01HS014580-01A1 (U.S. AHRQ Grant/Contract)
- HS014580 (Other Identifier: NIA- Administrative Supplement)
- 5R03HS018256 (U.S. AHRQ Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Disease
-
3-C Institute for Social DevelopmentUniversity of North Carolina, Chapel HillCompletedChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage IUnited States
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsRecruitingChronic Disease | Chronic Conditions, Multiple | Chronic ConditionDenmark
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsActive, not recruitingChronic Conditions, Multiple | Chronic ConditionDenmark
-
Universiti Putra MalaysiaRecruitingChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic DialysisMalaysia
-
Radboud University Medical CenterRecruitingChronic Conditions, Multiple | Chronic ConditionNetherlands
-
University of Alabama at BirminghamRecruitingDisability Physical | Chronic Conditions, Multiple | Chronic ConditionUnited States
-
National Taiwan University HospitalCompletedChronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
-
Centre Hospitalier le MansLe Mans UniversiteRecruitingFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease Stage 3BFrance
-
Radboud University Medical CenterRecruiting
-
Virta HealthActive, not recruitingDisease Progression | Chronic Disease | Telemedicine | Multiple Chronic Conditions | Long-Term CareUnited States
Clinical Trials on Guided Care
-
Cook County HealthCompletedAdult Inpatients Referred for Standard EchocardiographyUnited States
-
Wake Forest University Health SciencesCompletedOncology | Hematopoietic Cell TransplantationUnited States
-
University of FloridaTerminatedChemotherapy | Supportive Care | GenotypingUnited States
-
CoreAalst BVInsight Lifetech Co., Ltd.RecruitingCoronary Artery Disease | Acute Coronary SyndromeSpain, Belgium, China, Germany, Poland
-
University of California, San FranciscoSensible Medical Innovations Ltd.RecruitingHeart Failure; With DecompensationUnited States
-
Baker Heart and Diabetes InstituteQueen's University, Belfast; University of Melbourne; Heartwest; Western HealthRecruitingCoronary Artery Disease | Chronic Disease | Nurse's RoleAustralia
-
Bergen University CollegeUniversity of Bergen; University of StavangerCompletedCOPD | Diabetes Type 2Norway
-
The University of Texas Health Science Center,...Washington University School of Medicine; University of Michigan; John Ritter...Active, not recruiting
-
Chinese University of Hong KongWithdrawn
-
University Hospital Inselspital, BerneTerminated